Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome

被引：4
|
作者：
Lin, Che-Hung [1 ]
Yeh, Su-Peng [1 ,2 ,3 ]
Lin, Tze-Yi [1 ]
机构：
[1] China Med Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Taichung 404, Taiwan
[2] China Med Univ Hosp, Dept Med Res, Stem Cell Res Lab, Taichung 404, Taiwan
[3] China Med Univ, Taichung 404, Taiwan
来源：
ANNALS OF HEMATOLOGY | 2015年 / 94卷 / 11期
关键词：
FEBRILE NEUTROPHILIC DERMATOSIS;
D O I：
10.1007/s00277-015-2458-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1925 / 1926
页数：2
相关论文
共 50 条
  • [1] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Che-Hung Lin
    Su-Peng Yeh
    Tze-Yi Lin
    Annals of Hematology, 2015, 94 : 1925 - 1926
  • [2] Azacitidine for the treatment of myelodysplastic syndrome
    Cataldo, Vince D.
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 875 - 884
  • [3] Treatment of Myelodysplastic syndrome with azacitidine and erythropoietin
    Limaye, Sewanti
    Lipshitz, Jay
    Dulala, Renuka
    Patel, Dilip
    BLOOD, 2007, 110 (11) : 230B - 230B
  • [4] Ulcerative Sweet syndrome accompanied by interstitial lung disease and myelodysplastic syndrome
    Xu, Hong-Hui
    Xiao, Ting
    Gao, Xing-Hua
    Chen, Hong-Duo
    EUROPEAN JOURNAL OF DERMATOLOGY, 2009, 19 (04) : 411 - 412
  • [5] Azacitidine for Treatment of Therapy Related Myelodysplastic Syndrome
    Komrokji, Rami S.
    Al Ali, Najla H.
    Alrawi, E.
    Padron, Eric
    Perkins, Janelle
    Field, Teresa
    Lancet, Jeffrey E.
    List, Alan F.
    BLOOD, 2011, 118 (21) : 745 - 746
  • [6] Treatment outcome of 5′-azacitidine for myelodysplastic syndrome
    Kim, Y. K.
    Kim, H. J.
    Song, J. E.
    Kim, S. E.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    LEUKEMIA RESEARCH, 2013, 37 : S110 - S110
  • [7] Azacitidine (Vidaza) for myelodysplastic syndrome
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1201): : 11 - 11
  • [8] Treatment of myelodysplastic syndrome: Questions raised by the azacitidine experience
    Kantarjian, HM
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2415 - 2416
  • [9] Treatment of Advanced Myelodysplastic Syndrome With Demethylating Agents: Azacitidine
    Ades, Lionel
    Itzykson, Raphael
    Fenaux, Pierre
    SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 323 - 329
  • [10] Approval summary: Azacitidine for treatment of myelodysplastic syndrome subtypes
    Kaminskas, E
    Farrell, A
    Abraham, S
    Baird, A
    Hsieh, LS
    Lee, SL
    Leighton, JK
    Patel, H
    Rahman, A
    Sridhara, R
    Wang, YC
    Pazdur, R
    CLINICAL CANCER RESEARCH, 2005, 11 (10) : 3604 - 3608
12345